NFL Defends Eagles’ Handling of Jalen Hurts’ Blood Clots as Players Union Demands Investigation
PHILADELPHIA — The NFL is standing behind the Philadelphia Eagles’ medical staff following questions surrounding quarterback Jalen Hurts’ blood clot diagnosis, but the controversy is far from settled.
On Tuesday, the league defended Philadelphia’s handling of Hurts’ medical situation and reportedly decided against disciplining the organization.
However, the NFL Players Association is calling for a full investigation into the medical care Hurts received.
The disagreement raises questions about medical oversight, transparency, and player safety in professional football.
How the Situation Developed
Hurts initially reported discomfort in his left calf after being cleated during Philadelphia’s October 4 game against the Los Angeles Rams.
According to the Eagles, an ultrasound performed October 10 in London revealed a superficial vein thrombosis.
After consultation with medical professionals, Hurts was cleared to play against the Jacksonville Jaguars on October 11.
He participated in the game without reported limitations.
However, subsequent testing revealed that his condition had progressed.
On October 19, the Eagles and Hurts’ agent, Nicole Lynn, announced that the quarterback had been diagnosed with deep vein thrombosis and bilateral pulmonary emboli, meaning blood clots were present in both lungs.
Hurts is clinically stable and receiving treatment with blood thinners.
He is prohibited from participating in contact activities while undergoing treatment and is expected to miss the remainder of the season.
His representatives have expressed optimism about his recovery.
NFL Defends Philadelphia’s Medical Decisions
NFL Chief Medical Officer Dr. Allen Sills defended the Eagles’ handling of the situation Tuesday.
According to the league, Philadelphia’s medical staff coordinated with specialists in London and remained in communication with NFL medical officials throughout the process.
Sills characterized the medical approach as conservative and focused on the player’s well-being.
The NFL reportedly determined that Philadelphia did not violate its injury-reporting policies.
However, the NFLPA’s request for an investigation indicates that questions remain about the circumstances surrounding Hurts’ treatment and clearance.
What This Means for the Eagles
Beyond the medical concerns, Philadelphia must now navigate a difficult football situation without its franchise quarterback.
Hurts’ absence creates uncertainty for an organization with postseason expectations.
But the Eagles’ immediate competitive challenges are secondary to ensuring their quarterback receives appropriate treatment and makes a full recovery.
MCSN’s Take: Player Safety Deserves Transparency
The NFL’s defense of Philadelphia’s medical staff is significant, but it shouldn’t automatically end the conversation.
At the same time, the fact that Hurts’ condition worsened does not, by itself, establish that doctors made an improper decision.
Medical situations can change, and the public does not have access to every detail considered by the physicians involved.
That’s precisely why a thorough, independent review could be valuable.
If Philadelphia followed appropriate medical procedures, a review could reinforce confidence in those decisions.
If improvements are necessary, the league should be willing to make them.
This shouldn’t become a competition between the NFL and its players union over who controls the narrative.
The priority should be understanding what happened, protecting player health, and ensuring that every athlete can trust the medical decisions being made on their behalf.
Hurts’ recovery matters more than any football result.
